FDA Investigator Mutahar S Shamsi
Mutahar S Shamsi has conducted inspections on 17 sites in 1 countries as of 09 Nov 2009. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
09 Nov 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Mutahar S Shamsi:
Abby E Pelletier,
Alice C Silva,
Carla C Tuite,
Christopher A Demitrius,
Courtney N Long,
David C Sullivan,
David P Vanhouten,
Dolores Harper,
Dorothy W Lee,
Edward J Janik,
Eileen T Maher,
Elizabeth B Griffin,
Ellen P Madigan,
Eric C Schmitt,
Garry H Stewart,
George T Allen, Jr,
James P Finn,
James W Whitney,
Jason D Tenney,
Jeffrey J Thibodeau,
John A Sciacchitano,
Joyce A Kellett,
Justine M Corson,
Kathleen E Mcafoose,
Lauren M Lawrance,
Laurie B Frazier,
Leo B Zadecky,
Marcia M Laughrey,
Margaret E Walsh,
Maryam Tabatabaie,
Maura Rooney,
Megan A Haggerty,
Michael E Marcarelli,
Michael G Mayfield,
Michael J Leal,
Michael P Sweeney,
Michelle M Noe Varga,
Paul P Geraci,
Sandra P White,
Sara M Onyango,
Seth A Mailhot,
Shawn M Bogdan,
Stephen C Smith,
Steven M Ferrara,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Tamara S Rosbury,
Troy R Petrillo,
Yuan Fang
Mutahar S Shamsi's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2001 | FDA 483 Response | Integra LifeSciences Corporation - Integra Burlington - Form 483R, 2001-11-29 |
November, 2001 | EIR | Integra LifeSciences Corporation - Integra Burlington - EIR, 2001-11-07 |
December, 2001 | EIR | Hologic, Inc. - EIR, 2001-12-18 |
February, 2002 | FDA 483 | KMC Systems, Inc. - Form 483, 2002-02-20 |
November, 2001 | FDA 483 | Integra Burlington MA, Inc. - Form 483, 2001-11-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more